Skip to main content
SpringerLink
Log in

Tissue and Serum MUC1 Mucin Detection in Breast Cancer Patients

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Tumor MUC1 expression as well as levels of MUC1, MUC1 circulating immune complexes (MUC1-CIC) and free antibodies against MUC1 (IgG and IgM-MUC1) were evaluated in 70 breast cancer patients with different stages of disease. Controls included: 135 serum samples from healthy women, normal mammary tissue samples (n=7) and benign breast disease specimens (n=6). In all assays, pre- and post-vaccination serum samples from breast cancer patients belonging to a vaccination protocol developed at the Memorial Sloan Kettering Cancer Center (New York, USA) were included as controls. Serum MUC1 was measured through Cancer Associated Serum Antigen test and CA15-3 test. Employing ELISA, MUC1-CIC-IgG/M were measured with either C595 or SM3 monoclonal antibodies (MAb) as catchers and also free antibodies against MUC1 (IgG and IgM) using 100mer peptide as catcher. Employing multivariate statistical analysis, results were correlated with age, tumor type, stage of disease and grade of differentiation. By quantitative immunohistochemistry using three anti-MUC1 core protein MAbs (C595, HMFG2 and SM3), tumor MUC1 was detected in 60/70 (86%) breast cancer specimens which reacted with at least one of these MAbs. High MUC1 serum levels were detected in 14/67 (21%); IgG and IgM anti-MUC1 antibodies were found elevated in 32 and 14%, respectively, while IgG-MUC1-CIC-measured with C595 in 42% and IgM-MUC1-CIC in 54%; finally, SM3 was positive in 43 and 18%, respectively. Results of these studies demonstrate that in a group of breast cancer patients, MUC1 was detected both in tissue specimens as well as free in serum samples; furthermore, MUC1 can also circulate complexed with IgG and IgM antibodies; thus an accurate measurement should include free and complexed forms. On the other hand, immunohistochemical studies on breast cancer tissues may contribute to reveal different MUC1 glycoforms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Murray CJL, López AD: Mortality by cause for eight regions of the world: Global burden of disease study. Lancet 349: 1269–1276, 1977

    Google Scholar 

  2. Gendler SJ, Taylor-Papadimitriou J, Duhig T, Rothbar J, Burchell J: A highly immunogenic region of human polymorphic mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 263: 12820–12823, 1988

    Google Scholar 

  3. Gendler S, Lancaster C, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J, Pemberton EN, Lalani E, Wilson D: Molecular cloning and expression of human tumor polymorphic epithelial mucins. J Biol Chem 265: 15286–15293, 1990

    Google Scholar 

  4. Devine PL, Mc Guckin MA, Ramm LE, Ward BG, Pee D, Long S: Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon and prostate. Cancer 72: 2007–2015, 1993

    Google Scholar 

  5. Devine PL, McGuckin MA, Quinn R, Ward BG: Serum markers CASA and CA 15-3 in ovarian cancer: all MUC1 assays are not the same. Tumor Biol 15: 337–344, 1994

    Google Scholar 

  6. Croce MV, Isla-Larrain M, Price MR, Segal-Eiras A: Detection of circulating mammary mucin (MUC1) and MUC1 immune complexes (MUC1-CIC) in healthy women. Int J Biol Markers 16: 112–120, 2001

    Google Scholar 

  7. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J: Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 129: 255–265, 1995

    Google Scholar 

  8. Regimbald LH, Pilarski LM, Longenecker BM, Reddish MA, Zimmermann G, Hugh JC: The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Res 56: 4244–4249, 1996

    Google Scholar 

  9. Kam JL, Regimbald LH, Hilgers JH, Hoffman P, Krantz MJ, Longenecker BM, Hugh JC: MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats. Cancer Res 58: 5577–5581, 1998

    Google Scholar 

  10. Pandey P, Kharbanda S, Kufe D: Association of the DF3/MUC1 breast cancer antigen with Grb2 and Sos/Ras exchange protein. Cancer Res 55: 4000–4003, 1995

    Google Scholar 

  11. Li Y, Bharti A, Chen D, Gong J, Kufe D: Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma associated antigen and beta-catenin. Mol Cell Biol 18: 7216–7224, 1998

    Google Scholar 

  12. Taylor-Papadimitriou J, Burchell J, Dalziel M: MUC1 and cancer. Biochem Biophys Acta: 1455: 301–313, 1999

    Google Scholar 

  13. Brockhausen I, Yang JM, Burchell J, Whitehouse C, Taylor-Papadimitriou J: Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur J Biochem 233: 607–617, 1995

    Google Scholar 

  14. Muller S, Hanisch F-G: Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. J Biol Chem 277: 26103–26112, 2002

    Google Scholar 

  15. Barnd DL, Lan MS, Metzgar RS, Finn OJ: Specific, major histocompatibility complex unrestricted recognition of tumorassociated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 86: 7159–7163,1989

    Google Scholar 

  16. Jerome KR, Domenech N, Finn OJ: Tumor-specific cytotoxic T-cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. J Immunol 151: 1654–1662, 1993

    Google Scholar 

  17. Kotera Y, Darrell Fontenot J, Pecher G, Metzgar RS, Finn OJ: Humoral immunity against a tandem repeat epitope of human mucin MUC1 in sera from breast, pancreatic and colon cancer patients. Cancer Res 54: 2856–2860, 1994

    Google Scholar 

  18. Croce MV, Price MR, Segal-Eiras A: Expression of monoclonal antibody-defined antigens in fractions isolated from human breast carcinoma and patients' serum. Cancer Immunol Immunother 40: 132–137, 1995

    Google Scholar 

  19. Gouretvich MM, von Mensdorff-Pouilly S, Litvinov SV: Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. Br J Cancer 72: 934–938, 1995

    Google Scholar 

  20. Richards ER, Devine P, Quinn R, Darrell Fontenot J, Ward B, McGuckin M: Abs reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women. Cancer Immunol Immunother 46: 245–250, 1998

    Google Scholar 

  21. von Mensdorff-Pouilly S, Gouretvich MM, Kenemans P, Verstraeten AA, Litvinov SV, van Kamp GJ, Meijer S, Vermorken J, Hilgers J: Humoral immune response to polymorphic epithelial mucin (MUC1) in patients with benign and malignant breast tumors. Eur J Cancer 32A: 1325–1331, 1996

    Google Scholar 

  22. Croce MV, Isla-Larrain M, Capafons A, Price MR, Segal-Eiras A: Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women. Breast Cancer Res Treat 2044: 1–11, 2001

    Google Scholar 

  23. Musselli C, Livingston PO, Ragupathi G: Keyhole limpet hemocyanin conjugate vaccines against cancer: The Memorial Sloan Kettering experience. J Cancer Res Clin Oncol 127(Suppl 2): R20–26, 2001

    Google Scholar 

  24. Livingston PO, Zhang S, Old L: Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale. Cancer Immunol Immunother 45: 1–9, 1997

    Google Scholar 

  25. Jerome KR, Barnd DL, Bendt KM: Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 5: 2908–2915, 1991

    Google Scholar 

  26. Domenech N, Henderson RA, Finn OJ: Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. J Immunol 155: 4766, 1995

    Google Scholar 

  27. Musselli C, Ragupathi G, Gilewski T, Panageas K, Spinat Y, Livingston P: Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1. Int J Cancer 97: 660–667, 2002

    Google Scholar 

  28. Griffiths AB, Burchell J, Gendler S, Lewis A, Blight K, Tilly R, Taylor-Papadimitriou J: Immunological analysis of mucin molecules expressed by normal and malignant epithelial cells. Int J Cancer 40: 319–327, 1987

    Google Scholar 

  29. Croce MV, Colussi A, Price MR, Segal-Eiras A: Expression of tumour associated antigens in normal, benign and malignant human mammary epithelial tissue: a comparative immunohistochemical study. Anticancer Res 17: 4287–4292, 1997

    Google Scholar 

  30. Luna-Moré S, Rius F, Weil B, Jiménez A, Bautista MD, Pérez-Mellado A: EMA: a differentiation antigen related to node metastatic capacity of breast carcinomas. Pathol Res Pract 197: 419–425, 2001

    Google Scholar 

  31. Rahn JJ, Dabbagh L, Pasdar M, Hugh JC: The importance of MUC1 localization in patients with breast cancer. An immunological study of 71 patients and review of the literature. Cancer 91: 1973–1982, 2001

    Google Scholar 

  32. Kenemans P, Bast RC, Yemeda CA, Price MR, Hilgers J: Mucins and mucin-like antigens as tumor markers. In: Hilgers J, Zotter S (eds) Cancer Reviews. Copenhagen, Munksgaard, 1989, pp 19–44

    Google Scholar 

  33. Hayes DF, Sekine H, Ohno T, Abe M, Keefe K, Kufe DW: Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. J Clin Invest 75: 1671–1678, 1985

    Google Scholar 

  34. Gilewski T, Adluri S, Ragupathi G, Zhang HS, Yao T-J, Panageas K, Moynahan M, Houghton A, Norton L, Livingston PO: Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21. Clin Cancer Res 6: 1693–1701, 2000

    Google Scholar 

  35. Price MR, Pugh JA, Hudecz F, Griffiths W, Jacobs E, Symonds IM, Clarke AJ, Chan WC, Baldwin RW: C595-a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas. Br J Cancer 61: 681–686, 1990

    Google Scholar 

  36. Burchell J, Gendler S, Taylor-Papadimitriou J, Girling A, Lewis A, Millis R, Lamport D: Development and characterization of breast reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 47: 5476–5482, 1987

    Google Scholar 

  37. Taylor-Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL, Bodmer WF: Monoclonal antibodies to epithelium specific components of the milk fat globule membrane: production and reactions with cells in culture. Int J Cancer 28: 17–21, 1981

    Google Scholar 

  38. Layton GT, Devine P, Warren JA: Monoclonal antibodies reactive with the breast carcinoma-associated mucin coreprotein repeat sequence peptide also recognize the ovarian carcinoma-associated sebaceous gland antigen (SGA). Tumor Biol 11: 274–286, 1990

    Google Scholar 

  39. Price MR, Rye PD, Petrakou E, Murray A, Brady K, Imai S, Haga S, Kiyozuka Y, Schol D, Meulenbroek MF, Snijdewint FG, von Mensdorff-Pouilly S, Verstraeten RA, Kenemans P, Blockzjil A, Nilsson K, Nilsson O, Reddish M, Suresh MR, Koganty RR, Fortier S, Baronic L, Berg A, Longenecker MB, Hilgers J: Summary Report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. Tumor Biol 19(Suppl 1): 1–20, 1998

    Google Scholar 

  40. Burchell J, Taylor-Papadimitriou J, Boshell M, Gendler S, Duhig T: A short sequence, within the aminoacid tandem repeat of a cancer-associated mucin, contains immunodominants epitopes. Int J Cancer 44: 691–696, 1989

    Google Scholar 

  41. Möller H, Settas N, Paulsen H, Burchell J, Taylor-Papadimitriou J, Meyer B: NMR-based determination of the binding epitope and conformational analysis of the MUC1 glycopeptides and peptides bound to the breast cancer-selective monoclonal antibody SM3. Eur J Biochem 269: 1444–1455, 2002

    Google Scholar 

  42. Karsten U, Diotel C, Klich C, Paulsen H, Goletz S, Muller S, Hanisch F-G: Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by sitespecific glycosylation. Cancer Res 58: 2541–2549, 1998

    Google Scholar 

  43. Price MR, Hudecz F, O'Sullivan C, Baldwin RW, Edwards PM, Tendler SJB: Immunological and structural features of the protein core of human polymorphic epithelial mucin. Mol Immunol 27: 795–802, 1990

    Google Scholar 

  44. Taylor-Papadimitriou J, Burchell J, Miles DW, Dalziel M: MUC1 and Cancer Biochim Biophys Acta 1455: 301–313, 1999

    Google Scholar 

  45. Pemberton L, Taylor-Papadimitriou J, Gendler SR: Antibodies to the cytoplasmic domain of the MUC1 mucin shows conservation throughout mammals. Biochem Biophys Res Commun 185: 167–175, 1992

    Google Scholar 

  46. Rahn J, Dabbagh L, Pasdar M, Hugh JC: The importance of MUC1 cellular localization in patients with breast carcinoma. Cancer 91: 1973–1982, 2001

    Google Scholar 

  47. Kerin MJ, McAnena OJ, O'Malley VP, Grimes H, Given HF: CA 15-3 in patients with locoregional and metastatic breast cancer. Br J Surg 76: 838–839, 1989

    Google Scholar 

  48. Cannon PM, Ellis IO, Blamey RW, Bell J, Elston CW, Robertson JF: Expression of tumour-associated antigens in breast cancer primary tissue compared with serum levels. Eur J Surg Oncol 19: 523–527, 1993

    Google Scholar 

  49. von Mensdorff-Pouilly S, Petrakou E, Kenemans P, van Uffelen K, Verstraeten AA, Snidjdewint FGM, van Kamp GJ, Schol DJ, Reis CA, Price MR, Livingston PO, Hilgers J: Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and N-actylgalactosamine (GalNAc) peptides. Int J Cancer 86: 702–712, 2000

    Google Scholar 

  50. Hiltbold EM, Vlad AM, Ciborowski P, Finn OJ, Watkins SC, Finn OJ: The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells. J Immunol 165: 3730–3741, 2000

    Google Scholar 

  51. Hiltbold EM, Alter MD, Ciborowski P, Finn OJ: Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken up by dendritic cells. Cellul Immunol 194: 143–149, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro de Investigaciones Inmunológicas Básicas y Aplicadas, Facultad de Ciencias Médicas, UNLP, La Plata, Argentina

    María V. Croce (Prof Amada Segal-Eiras and Dr María Virginia Croce are members of the Research Career of the CONICET (Consejo de Nacional de Investigaciones Científicas y Tecnológicas) and CICPBA (Comisión de Investigaciones de la Provincia de Buenos Aires, Argentina), respectively), Marina T. Isla-Larrain, Sandra O. Demichelis & Amada Segal-Eiras

  2. Servicio de Ginecología, Hospital Alemán, Buenos Aires, Argentina

    Jorge R. Gori

  3. Cancer Research Laboratory, School of Pharmaceutical Sciences, University of Nottingham, UK

    Mike R. Price

Authors
  1. María V. Croce
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marina T. Isla-Larrain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandra O. Demichelis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amada Segal-Eiras
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jorge R. Gori
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mike R. Price
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Croce, M.V., Isla-Larrain, M.T., Demichelis, S.O. et al. Tissue and Serum MUC1 Mucin Detection in Breast Cancer Patients. Breast Cancer Res Treat 81, 195–207 (2003). https://doi.org/10.1023/A:1026110417294

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026110417294

Search

Navigation